Stephens Inc Puma Biotechnology, Inc. Transaction History

Stephens Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$12.3 - $35.76 $75,989 - $220,925	-6,178 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$20.77 - $42.37 $128,317 - $261,761	6,178 New	6,178 $240,000
Q4 2018 Feb 11, 2019	SELL	$20.07 - $46.7 $102,778 - $239,150	-5,121 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $210,985 - $306,491	5,121 New	5,121 $235,000
Q3 2017 Nov 08, 2017	SELL	$72.0 - $119.75 $324,000 - $538,875	-4,500 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	4,500	4,500 $393,000

30.5M

73.5K

18.5K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $118M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

Stay updated on Stephens Inc with notifications on news.